Get started
Author

Alexander Pichler

Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
2023 · Martin Bendszus, Jens Fiehler, et al. · The Lancet · 481
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
2021 · Christoph Kornauth, Tea Pemovska, et al. · Cancer Discovery · 200
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
2020 · Götz Thomalla, Florent Boutitie, et al. · The Lancet · 193
PDF
Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke
2015 · Matthew Traylor, Cathy R. Zhang, et al. · Neurology · 96
PDF
Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial
2024 · Götz Thomalla, Jens Fiehler, et al. · The Lancet Neurology · 79
PDF
Early complications and radiological outcome after distal radius fractures stabilized by volar angular stable locking plate
2018 · Stefan Quadlbauer, Ch. Pezzei, et al. · Archives of Orthopaedic and Trauma Surgery · 59
Functional and radiological outcome of distal radius fractures stabilized by volar-locking plate with a minimum follow-up of 1 year
2020 · Stefan Quadlbauer, Ch. Pezzei, et al. · Archives of Orthopaedic and Trauma Surgery · 45
Genetic variants in CETP increase risk of intracerebral hemorrhage
2016 · Christopher D. Anderson, Guido J. Falcone, et al. · Annals of Neurology · 40
PDF
Arterial Collaterals and Endovascular Treatment Effect in Acute Ischemic Stroke with Large Infarct: A Secondary Analysis of the TENSION Trial
2025 · Laurens Winkelmeier, Helge Kniep, et al. · Radiology · 26
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas
2023 · Hannes Vietzen, Philipp B. Staber, et al. · Frontiers in Immunology · 18
Core-binding factor leukemia hijacks the T-cell–prone PU.1 antisense promoter
2021 · E. van der Kouwe, G. Heller, et al. · Blood · 16
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
2024 · Tobias Suske, Helena Sorger, et al. · Journal of Clinical Investigation · 13
Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets
2024 · Alexander S Pichler, Catalina Amador, et al. · Histopathology · 10
PDF
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
2025 · Helge C. Kniep, Susanne Gellißen, et al. · Stroke · 8
Comparing functional and genomic‐based precision medicine in blood cancer patients
2025 · Lukas Kazianka, Alexander Pichler, et al. · HemaSphere · 6
PDF
Functional Precision Medicine Vs Genomics Vs Clinical Experience: Feasibility Results from the Multicentric, Prospective, Randomized Controlled Exalt-2 Trial
2023 · Lukas Kazianka, Tea Pemovska, et al. · Blood · 5
Interstitial Lung Disease Associated Acute Respiratory Failure Requiring Invasive Mechanical Ventilation: A Retrospective Analysis
2020 · Cyrus Vahdatpour, Alexander Pichler, et al. · The Open Respiratory Medicine Journal · 5
PDF
T-Cell Large Granular Lymphocyte Leukemia: An Interdisciplinary Issue?
2022 · Johanna Schreiber, Alexander Pichler, et al. · Frontiers in Oncology · 4
PDF
Treatment Guided By Next Generation Functional Drug Screening Provides Clinical Benefit in Advanced Aggressive Hematological Malignancies: Final Evaluation of the Open Label, Single Arm Exalt Trial
2020 · Christoph Kornauth, Tea Pemovska, et al. · Blood · 2
Abstract GS6-04: The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2- breast cancer patients from ABCSG 34
2018 · PC Dubsky, C Fesl, et al. · Cancer Research · 2
Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib
2023 · Alexander Pichler, Christoph Kornauth, et al. · Blood · 1
PDF
News on Peripheral T-cell lymphoma
2023 · Alexander Pichler · memo - Magazine of European Medical Oncology · 1
PDF
STAT5 Gain-of-Function Variants Promote Precursor T-Cell Receptor Activation to Drive T-Cell Acute Lymphoblastic Leukemia
2022 · Tobias Suske, Helena Sorger, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Ablation of CDK6 and STAT5B rewires T cell developmental dynamics and prevents ALK+ lymphoma formation
2026 · Jonatan Kendler, Maximilian Sexl, et al. · Nature Communications
PDF
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression
2026 · Linus Wahnschaffe, Dennis Jungherz, et al. · Nature Communications
Works count: 34
Citation count: 1,311
H-index: 12
I10-index: 13
Year
Topic
Type